
QIAGEN N.V. QGEN
Geschäftsbericht 2025
hinzugefügt 18.04.2026
QIAGEN N.V. Gesamtverbindlichkeiten 2011-2026 | QGEN
Gesamtverbindlichkeiten Jährlich QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 3.11 B | 2.7 B | 3.11 B | 2.5 B | 1.7 B | 1.63 B | 1.8 B | 1.36 B | 1.36 B | 1.2 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.11 B | 1.2 B | 2.05 B |
Gesamtverbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
4.11 M | $ 1.27 | -22.09 % | $ 1.69 M | ||
|
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
90.8 M | $ 15.81 | -2.35 % | $ 478 M | ||
|
Agilent Technologies
A
|
5.32 B | $ 111.6 | -1.45 % | $ 33.9 B | ||
|
Castle Biosciences
CSTL
|
108 M | $ 19.18 | 1.59 % | $ 556 M | ||
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
2.7 B | $ 141.04 | -1.54 % | $ 22.4 B | ||
|
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
11.5 M | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
110 M | $ 19.85 | -3.12 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
1.14 B | $ 93.57 | -3.21 % | $ 6.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
1.52 B | $ 417.23 | -0.46 % | $ 12 B | ||
|
Mettler-Toledo International
MTD
|
3.74 B | $ 1 037.75 | -0.4 % | $ 21.4 B | ||
|
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
339 M | $ 3.62 | -0.14 % | $ 335 M | ||
|
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
523 M | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
Charles River Laboratories International
CRL
|
3.92 B | $ 153.0 | -3.85 % | $ 7.58 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | ||
|
National Research Corporation
NRC
|
121 M | $ 18.63 | -1.61 % | $ 417 M | ||
|
Natera
NTRA
|
689 M | $ 188.85 | -4.1 % | $ 18.6 B | ||
|
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
16 B | $ 25.25 | -0.98 % | $ 23.9 B | ||
|
Guardant Health
GH
|
2.11 B | $ 94.7 | -4.02 % | $ 11.9 B | ||
|
Senseonics Holdings
SENS
|
65.2 M | $ 5.72 | -1.8 % | $ 239 M | ||
|
Personalis
PSNL
|
73 M | $ 6.46 | -3.73 % | $ 576 M | ||
|
Soleno Therapeutics
SLNO
|
114 M | $ 53.0 | 0.02 % | $ 2.69 B | ||
|
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
7.35 B | $ 117.71 | 0.53 % | $ 9.71 B | ||
|
Biomerica
BMRA
|
1.84 M | $ 2.36 | -2.12 % | $ 5.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 252.45 | -0.62 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
28.7 B | $ 438.41 | -2.17 % | $ 165 B | ||
|
Trinity Biotech plc
TRIB
|
138 M | $ 0.56 | -3.63 % | $ 201 M | ||
|
Celcuity
CELC
|
366 M | $ 135.32 | 0.45 % | $ 6.33 B | ||
|
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
169 M | $ 48.53 | -8.35 % | $ 2.9 B | ||
|
Neogen Corporation
NEOG
|
1.37 B | $ 8.22 | -2.55 % | $ 1.78 B | ||
|
Waters Corporation
WAT
|
2.52 B | $ 330.33 | -0.86 % | $ 19.7 B | ||
|
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 186.95 | -0.53 % | $ 20.8 B |